Quest Diagnostics Incorporated (DGX) - Total Liabilities
Based on the latest financial reports, Quest Diagnostics Incorporated (DGX) has total liabilities worth $9.01 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Quest Diagnostics Incorporated - Total Liabilities Trend (1996–2025)
This chart illustrates how Quest Diagnostics Incorporated's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Quest Diagnostics Incorporated's working capital to evaluate short-term liquidity relative to the company's equity base.
Quest Diagnostics Incorporated Competitors by Total Liabilities
The table below lists competitors of Quest Diagnostics Incorporated ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Veralto Corporation
NYSE:VLTO
|
USA | $4.58 Billion |
|
Expand Energy Corporation
NASDAQ:EXE
|
USA | $9.97 Billion |
|
Guangdong Songfa Ceramics Co
SHG:603268
|
China | CN¥46.43 Billion |
|
CIMB Group Holdings Bhd
KLSE:1023
|
Malaysia | RM706.82 Billion |
|
Cognizant Technology Solutions Corp Class A
NASDAQ:CTSH
|
USA | $5.43 Billion |
|
Hapag Lloyd AG
XETRA:HLAG
|
Germany | €11.58 Billion |
|
CyberArk Software Ltd
NASDAQ:CYBR
|
USA | $2.41 Billion |
|
King Slide Works Co Ltd
TW:2059
|
Taiwan | NT$7.96 Billion |
Liability Composition Analysis (1996–2025)
This chart breaks down Quest Diagnostics Incorporated's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Quest Diagnostics Incorporated stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Quest Diagnostics Incorporated's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Quest Diagnostics Incorporated (1996–2025)
The table below shows the annual total liabilities of Quest Diagnostics Incorporated from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $8.94 Billion | -3.44% |
| 2024-12-31 | $9.26 Billion | +21.74% |
| 2023-12-31 | $7.60 Billion | +11.33% |
| 2022-12-31 | $6.83 Billion | -3.11% |
| 2021-12-31 | $7.05 Billion | -1.21% |
| 2020-12-31 | $7.13 Billion | +0.78% |
| 2019-12-31 | $7.08 Billion | +25.11% |
| 2018-12-31 | $5.66 Billion | +3.49% |
| 2017-12-31 | $5.47 Billion | +1.96% |
| 2016-12-31 | $5.36 Billion | +3.55% |
| 2015-12-31 | $5.18 Billion | -6.63% |
| 2014-12-31 | $5.55 Billion | +11.50% |
| 2013-12-31 | $4.97 Billion | -2.41% |
| 2012-12-31 | $5.10 Billion | -8.94% |
| 2011-12-31 | $5.60 Billion | +25.14% |
| 2010-12-31 | $4.47 Billion | -1.73% |
| 2009-12-31 | $4.55 Billion | -5.14% |
| 2008-12-31 | $4.80 Billion | -8.44% |
| 2007-12-31 | $5.24 Billion | +98.37% |
| 2006-12-31 | $2.64 Billion | +3.90% |
| 2005-12-31 | $2.54 Billion | +32.79% |
| 2004-12-31 | $1.92 Billion | +0.44% |
| 2003-12-31 | $1.91 Billion | +22.59% |
| 2002-12-31 | $1.56 Billion | -2.46% |
| 2001-12-31 | $1.59 Billion | -13.00% |
| 2000-12-31 | $1.83 Billion | -9.06% |
| 1999-12-31 | $2.02 Billion | +154.37% |
| 1998-12-31 | $792.30 Million | -7.79% |
| 1997-12-31 | $859.20 Million | +0.33% |
| 1996-12-31 | $856.35 Million | -- |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagn… Read more